arrow
C

Christoph Male

University of California System
H指数:47
被引数:8,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of anticoagulation for pediatric cerebral sinovenous thrombosis: systematic review and meta-analysis

抗凝治疗对儿童脑静脉窦血栓形成疗效和安全性的系统评价与Meta分析

2026-08-010
PRE
Efficacy and safety of recombinant von Willebrand factor in on-demand treatment of children with von Willebrand disease: up to 4 years of phase 3/3b follow-up

重组血管性血友病因子在血管性血友病患者儿童按需治疗中的有效性和安全性:长达4年的III/IIIb期随访

2026-08-010
PRE
Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group

儿童抗血栓药物新药研发(第一部分):来自国际血栓与止血学会科学和标准委员会儿科与新生儿血栓症和止血学分会及Pedi-ATLAS小组的指导

2026-04-110
PRE
ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism

ASH ISTH 2026年关于静脉血栓栓塞症高风险儿科患者抗凝预防的指南

2026-04-080
OAAI
Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis

儿童静脉血栓栓塞症溶栓治疗的有效性与安全性:一项系统评价和Meta分析

2025-06-270
OAAI
Systematic analysis of the design, methodology, and patient population characteristics of the pediatric direct oral anticoagulant trials of venous thromboembolism treatment

儿科静脉血栓栓塞症治疗直接口服抗凝剂试验的设计、方法学和患者人群特征的系统分析

2025-01-010
PRE
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
2024-12-090
PRE
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal
2024-12-060
PREAI
The Functional Characterization of Venous Thromboembolic Disease (FUVID) study: rationale, design, and methods of a prospective, observational, multicenter study to evaluate mechanisms of exercise intolerance and dyspnea following pediatric pulmonary embolism

静脉血栓栓塞性疾病 (FUVID) 研究的功能特征: 前瞻性,观察性,多中心研究的原理,设计和方法,以评估小儿肺栓塞后运动不耐受和呼吸困难的机制

2024-12-010
OAAI